Post Q3 EVC Update
EVC's Q3 update cites $30 million for a single station, a broadcast-business sale and stronger positioning for 2027.
EVC's Q3 update cites $30 million for a single station, a broadcast-business sale and stronger positioning for 2027.
$NN https://t.co/zzA15wtgMZ
Got the $SITC dividend of $3 last night and used it to buy $ARI today which no longer trades as of 4pm today Sometimes you get to buy a luxury apartment tower in Downtown Brooklyn and get two hotels for free Managed to thread the needle Hope to get a hat trick in liquidations with $ELME $SITC and $ARI
You been long $PCT for some time. And communicating with he of the Pink Dildo Fund. I mean Mike must be very smart. He think that Dan Gibson is a genius - and that is his refutation of my PCT short. (My thesis is simple: Dan Gibson is an idiot. My thesis does not involve Mike Taylor.) https://t.co/kDkDVkfDSl
@Mike_Taylor1972 @LevelUp975 Yes Sir. $PCT is the flagship stock in your Pink Dildo Fund. 🍆
2 nice blowups of two of my largest shorts today. $NRDS down 30% and $BL down 20%. Closing half of my $BL as it's no longer silly, and it's a decent business. Am considering adding to $NRDS as this result confirms the bear thesis that they are having to pay more for traffic.
Transocean’s 25.6% selloff reflects oil-market shorting and weak Q3 headlines, while debt reduction after the Valaris acquisition could…
Alpha Metallurgical posted a third consecutive quarterly loss as High Vol A coal margins fell to $14 a ton, while director Kenneth Courtis…
Shift4’s Q3 met guidance, but organic growth is decelerating, management credibility is weakening and leverage reduction remains too slow.
Diversified Energy reported $255.6 million of “true” nine-month free cash flow, while its $1.8 billion Birch acquisition would shift…
Vicor earns a Strong Buy after record Q3 results and AI gains, while QXO falls to Hold over capital structure and execution risk.
TransMedics reported record Q3 2026 revenue exceeding $200 million, driven by its organ transplant technology business.
JFrog jumped 35% to $100.44 after another beat-and-raise quarter, joining the TL20 Special Situations group.
Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…
Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…
PTRN · short Pattern Group is a fragile consumer business targeted on the short side.
Amplitude reported Q2 revenue of $100.9 million, up 21%, as agentic AI and LLM vendors challenge the moat of its product analytics software.
Kosmos Energy (KOS) is pitched as an oil stock poised to outperform if oil stays above $70-$80, supported by a claimed 2 billion-barrel…
Signet, Medipal and First REIT headline 27 situations spanning buybacks, activism, M&A and liquidation catalysts.
Owens Corning's roofing business has historically posted sharp EBITDA and share-price gains during El Niño storm years, as severe weather…
Vicor’s 48-volt power modules cut current and resistive losses for high-power AI processors by converting voltage at the chip.
Dyne Therapeutics fell 16% after Novartis’ HARBOR failure raised doubts that RNA-targeting biomarker gains translate into functional…
ContextLogic will acquire specialty-solvent maker gChem for $850 million, funded by a $650 million rights offering and $250 million of…
Tecnoglass could recover tariff- and FX-hit margins as U.S. blanket tariffs on Colombian goods lift.
Scholar Rock’s apitegromab could become the first muscle-targeted SMA therapy by September 2026, but manufacturing setbacks and a…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.